Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Light

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2012
Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchangeDaniel Soliman, Lianguo Wang, Kevin S C Hamming, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 2, 2017
Hearts lacking plasma membrane K<sub>ATP</sub> channels display changes in basal aerobic metabolic substrate preference and AMPK activityNermeen Youssef, Scott Campbell, Amy Barr, et al.
The Journal of Biological Chemistry|June 20, 2008
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and AktAnita Y M Chan, Vernon W Dolinsky, Carrie-Lynn M Soltys, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 19, 2005
Plasma membrane KATP channel-mediated cardioprotection involves posthypoxic reductions in calcium overload and contractile dysfunction: mechanistic insights into cardioplegiaIstván Baczkó, Lynn Jones, Claire F McGuigan, et al.
Journal of Molecular and Cellular Cardiology|December 4, 2024
The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific mannerLynn C Lunsonga, Mohammad Fatehi, Wentong Long, et al.
Molecular Metabolism|May 16, 2020
Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetesScott A Campbell, Dominic P Golec, Matt Hubert, et al.
The Journal of Biological Chemistry|September 25, 2008
The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptorMelissa J S Chee, Karin Mörl, Diana Lindner, et al.
Nature Communications|January 13, 2015
A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteinsJessica T Y Yue, Mona A Abraham, Mary P LaPierre, et al.
Molecular Metabolism|March 18, 2014
Hypothalamic glucagon signals through the KATP channels to regulate glucose productionMona A Abraham, Jessica T Y Yue, Mary P LaPierre, et al.
Plos One|August 14, 2020
Selective enhancement of cardiomyocyte efficiency results in a pernicious heart conditionJody Groenendyk, Qian Wang, Cory Wagg, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|August 11, 2012
Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchangeDaniel Soliman, Lianguo Wang, Kevin S C Hamming, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 2, 2017
Hearts lacking plasma membrane K<sub>ATP</sub> channels display changes in basal aerobic metabolic substrate preference and AMPK activityNermeen Youssef, Scott Campbell, Amy Barr, et al.
The Journal of Biological Chemistry|June 20, 2008
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and AktAnita Y M Chan, Vernon W Dolinsky, Carrie-Lynn M Soltys, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 19, 2005
Plasma membrane KATP channel-mediated cardioprotection involves posthypoxic reductions in calcium overload and contractile dysfunction: mechanistic insights into cardioplegiaIstván Baczkó, Lynn Jones, Claire F McGuigan, et al.
Journal of Molecular and Cellular Cardiology|December 4, 2024
The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific mannerLynn C Lunsonga, Mohammad Fatehi, Wentong Long, et al.
Molecular Metabolism|May 16, 2020
Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetesScott A Campbell, Dominic P Golec, Matt Hubert, et al.
The Journal of Biological Chemistry|September 25, 2008
The third intracellular loop stabilizes the inactive state of the neuropeptide Y1 receptorMelissa J S Chee, Karin Mörl, Diana Lindner, et al.
Nature Communications|January 13, 2015
A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteinsJessica T Y Yue, Mona A Abraham, Mary P LaPierre, et al.
Molecular Metabolism|March 18, 2014
Hypothalamic glucagon signals through the KATP channels to regulate glucose productionMona A Abraham, Jessica T Y Yue, Mary P LaPierre, et al.
Plos One|August 14, 2020
Selective enhancement of cardiomyocyte efficiency results in a pernicious heart conditionJody Groenendyk, Qian Wang, Cory Wagg, et al.
Pageof 8